American multinational medical devices and health care company Abbott (NYSE: ABT) and the National Association of Community Health Centers (NACHC) announced on Monday a multi-year 'food is medicine' effort, called the NACHC and Abbott Food for Health Initiative, aimed at making healthy, nutritious food a core part of primary healthcare at Community Health Centers (CHCs) across the US.
The NACHC-Abbott partnership will include a national certification program designed to help CHCs develop the systems and capacity to advance food for health, along with structured learning, training and knowledge-sharing for CHC staff to build capabilities and expertise in addressing immediate nutrition needs, integrating nutrition into healthcare delivery, and preventing and managing nutrition-related chronic diseases.
The framework is made up of three key components: Food for Health Learning Lab, a structured learning program designed to build nutrition literacy and expertise across the CHC workforce, and guide health centres in implementing and measuring food is medicine efforts; Food for Health Community of Practice, a national peer-learning network that will connect health centres to share promising practices, troubleshoot challenges and learn from top experts; Food for Health CORE (Certification of Readiness and Excellence), a voluntary national certification program that will recognize and support CHCs in developing the systems, processes and competencies needed to advance food for health efforts.
The NACHC and Abbott Food for Health Initiative is a signature program of NACHC's Center for Nutrition and Health, bringing together public and private partners, CHCs, and other stakeholders. The centre's broader goal is to serve as an innovation hub dedicated to moving food-based clinical care from separate efforts to a coordinated body of programs and policy initiatives that improve health outcomes.
Tristel launches premium 3T Pro digital compliance platform
Insulet expands European footprint with Omnipod 5 and Omnipod Discover launch in Spain
Frontier IP portfolio company InSignals wins EU grant and launches Parkinson's app
PharmaResearch to acquire CG USA to support North American expansion of REJURAN Cosmetics
United Therapeutics wins FDA approval for LungFX ex vivo lung perfusion device
Natera Signatera gains PMDA approval in Japan for colorectal cancer testing
Getinge launches Fluobeam LS for fluorescence‑guided small‑incision surgery
Airiver Medical treats first chronic rhinosinusitis patient in Drug Coated Balloon clinical study
Galmed Pharmaceuticals to acquire Colospan for GI-focused platform development
Medtronic seeks expanded US approvals for Hugo robotic surgery system
Waters secures FDA clearance for BD BACTEC FXI Blood Culture System
MiniMed expands Abbott partnership for dual glucose-ketone diabetes sensors